ABK Courts Angels Outside Region
Halifax medical device company ABK Biomedical is raising about $1 million in equity financing to help get its product on the European market in about a year. While it’s secured about half the total from the First Angel Network, or FAN, it’s also working with the local investment group to engage with other angel networks in Canada and the U.S.
ABK is the developer of OccluRad — tiny bio-compatible glass beads used to treat uterine fibroids, or benign tumours, in a woman’s uterus. The product improves efficiency and safety when treating women for the affliction. The company hopes to have